2Fastboy.Benchmark

Quanome Technologies, Inc. (QNME) fundamentals score

Prior to February 12, 2026, in addition to engaging in the distribution of pharmaceutical products through Hupan Pharmaceutical, Quanome Technologies also operateds as a U.S.-based integrated cross-border supply chain solutions provider with a strategic focus on the Asian market.

Arrangement of Transportation of Freight & Cargo · Industrials · Listed on NASDAQ

Overall: 3.3 out of 10, Unhealthy fundamentals

  • Growth: 2.0/10
  • Profitability: 2.5/10
  • Financial health: 4.5/10
  • Earnings quality: 7.0/10
  • Valuation: 1.5/10

Scores are calculated from Quanome Technologies, Inc.’s SEC filings, using the 12 months through 2026-06. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.

Other Industrials stocks

Compare QNME with SEZL · Screen all stocks